Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Santoni

Showing results (51-60 of 459) with videos related to

Pageof 46
Sort By:
Frontiers in Oncology|May 21, 2019
Editorial: Emerging Biomarkers in Genitourinary TumorsRodolfo Montironi, Matteo Santoni, Alessia Cimadamore, et al.
Medical Sciences (Basel, Switzerland)|December 6, 2019
Transient Receptor Potential Cation Channels in Cancer TherapyGiorgio Santoni, Federica Maggi, Maria Beatrice Morelli, et al.
Seminars in Cancer Biology|September 18, 2021
Microbiota and prostate cancerAlessandro Rizzo, Matteo Santoni, Veronica Mollica, et al.
Cancer Treatment Reviews|June 17, 2016
Economic sustainability of anti-PD-1 agents nivolumab and pembrolizumab in cancer patients: Recent insights and future challengesFrancesca Tartari, Matteo Santoni, Luciano Burattini, et al.
European Urology|February 7, 2021
Re: Human Chimeric Antigen Receptor Macrophages for Cancer ImmunotherapyMatteo Santoni, Francesco Massari, Giorgio Santoni, et al.
Expert Opinion on Biological Therapy|June 20, 2024
Do we need alternative PD-1 inhibitors for the treatment of renal cell carcinoma?Matteo Rosellini, Andrea Marchetti, Elisa Tassinari, et al.
Expert Review of Anticancer Therapy|August 27, 2021
Antitumor effects of the multi-target tyrosine kinase inhibitor cabozantinib: a comprehensive review of the preclinical evidenceMatteo Santoni, Roberto Iacovelli, Valentina Colonna, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|October 14, 2022
MiT translocation renal cell carcinoma: A review of the literature from molecular characterization to clinical managementMimma Rizzo, Gaetano Pezzicoli, Matteo Santoni, et al.
European Urology|July 29, 2015
Re: Johan Lindberg, Anna Kristiansen, Peter Wiklund, Henrik Grönberg, Lars Egevad. Tracking the Origin of Metastatic Prostate Cancer. Eur Urol 2015;67:819-22Francesco Piva, Matteo Santoni, Marina Scarpelli, et al.
Future Oncology (London, England)|December 20, 2021
Risk of toxicity with immunotherapy-tyrosine kinase inhibitors for metastatic renal cell carcinoma: a meta-analysis of randomized controlled trialsAlessandro Rizzo, Veronica Mollica, Matteo Santoni, et al.
Pageof 46

Showing results (51-60 of 459) with videos related to

Sort By:
Pageof 46
Frontiers in Oncology|May 21, 2019
Editorial: Emerging Biomarkers in Genitourinary TumorsRodolfo Montironi, Matteo Santoni, Alessia Cimadamore, et al.
Medical Sciences (Basel, Switzerland)|December 6, 2019
Transient Receptor Potential Cation Channels in Cancer TherapyGiorgio Santoni, Federica Maggi, Maria Beatrice Morelli, et al.
Seminars in Cancer Biology|September 18, 2021
Microbiota and prostate cancerAlessandro Rizzo, Matteo Santoni, Veronica Mollica, et al.
Cancer Treatment Reviews|June 17, 2016
Economic sustainability of anti-PD-1 agents nivolumab and pembrolizumab in cancer patients: Recent insights and future challengesFrancesca Tartari, Matteo Santoni, Luciano Burattini, et al.
European Urology|February 7, 2021
Re: Human Chimeric Antigen Receptor Macrophages for Cancer ImmunotherapyMatteo Santoni, Francesco Massari, Giorgio Santoni, et al.
Expert Opinion on Biological Therapy|June 20, 2024
Do we need alternative PD-1 inhibitors for the treatment of renal cell carcinoma?Matteo Rosellini, Andrea Marchetti, Elisa Tassinari, et al.
Expert Review of Anticancer Therapy|August 27, 2021
Antitumor effects of the multi-target tyrosine kinase inhibitor cabozantinib: a comprehensive review of the preclinical evidenceMatteo Santoni, Roberto Iacovelli, Valentina Colonna, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|October 14, 2022
MiT translocation renal cell carcinoma: A review of the literature from molecular characterization to clinical managementMimma Rizzo, Gaetano Pezzicoli, Matteo Santoni, et al.
European Urology|July 29, 2015
Re: Johan Lindberg, Anna Kristiansen, Peter Wiklund, Henrik Grönberg, Lars Egevad. Tracking the Origin of Metastatic Prostate Cancer. Eur Urol 2015;67:819-22Francesco Piva, Matteo Santoni, Marina Scarpelli, et al.
Future Oncology (London, England)|December 20, 2021
Risk of toxicity with immunotherapy-tyrosine kinase inhibitors for metastatic renal cell carcinoma: a meta-analysis of randomized controlled trialsAlessandro Rizzo, Veronica Mollica, Matteo Santoni, et al.
Pageof 46